{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:20:25Z","timestamp":1791645625765,"version":"4.3.4"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2018,3,26]],"date-time":"2018-03-26T00:00:00Z","timestamp":1522022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["KL2 TR 000446"],"award-info":[{"award-number":["KL2 TR 000446"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1 TR000445"],"award-info":[{"award-number":["UL1 TR000445"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007206","name":"Vanderbilt Institute for Clinical and Translational Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007206","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","award":["IRSA 1015006"],"award-info":[{"award-number":["IRSA 1015006"]}],"id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1P50GM115305-01"],"award-info":[{"award-number":["1P50GM115305-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01AI103348-01"],"award-info":[{"award-number":["1R01AI103348-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1P30AI110527-01A1"],"award-info":[{"award-number":["1P30AI110527-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5T32AI007474-20"],"award-info":[{"award-number":["5T32AI007474-20"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1 R13AR71267-01"],"award-info":[{"award-number":["1 R13AR71267-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Health and Medical Research Council of Australia"},{"DOI":"10.13039\/100009781","name":"Australian Centre for HIV and Hepatitis Virology Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"abstract":"<jats:p>In this matched-cohort study of pediatric inpatients, 28.9% of those treated with a combination of piperacillin\u2013tazobactam and vancomycin developed acute kidney injury, compared to 7.9% in those treated with cefepime and vancomycin (P &lt; .001).<\/jats:p>","DOI":"10.1093\/jpids\/piy030","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T15:16:30Z","timestamp":1519658190000},"page":"221-227","source":"Crossref","is-referenced-by-count":40,"title":["Incidence of Nephrotoxicity Among Pediatric Patients Receiving Vancomycin With Either Piperacillin\u2013Tazobactam or Cefepime: A Cohort Study"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5097-758X","authenticated-orcid":false,"given":"Kathryn M","family":"Cook","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Gillon","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison G","family":"Grisso","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Banerjee","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Jimenez-Truque","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J","family":"Phillips","sequence":"additional","affiliation":[{"name":"Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara L","family":"Van Driest","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee"},{"name":"Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,3,26]]},"reference":[{"key":"2019101003055490000_CIT0001","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/archpedi.157.1.60","article-title":"Incidence and impact of adverse drug events in pediatric inpatients","volume":"157","author":"Holdsworth","year":"2003","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2019101003055490000_CIT0002","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1542\/peds.2005-2429","article-title":"Adverse drug reactions among children over a 10-year period","volume":"118","author":"Le","year":"2006","journal-title":"Pediatrics"},{"key":"2019101003055490000_CIT0003","volume-title":"Vancomycin hydrochloride","author":"U.S. National Library of Medicine"},{"key":"2019101003055490000_CIT0004","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s00228-012-1259-9","article-title":"Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review","volume":"68","author":"Elyasi","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"2019101003055490000_CIT0005","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists","volume":"66","author":"Rybak","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"2019101003055490000_CIT0006","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1128\/AAC.01602-07","article-title":"Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity","volume":"52","author":"Lodise","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"2019101003055490000_CIT0007","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/AAC.01568-12","article-title":"Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter","volume":"57","author":"van Hal","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2019101003055490000_CIT0008","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/phar.1738","article-title":"Comparative incidence of acute kidney injury in critically ill patients receiving vancomycin with concomitant piperacillin\u2013tazobactam or cefepime: a retrospective cohort study","volume":"36","author":"Hammond","year":"2016","journal-title":"Pharmacotherapy"},{"key":"2019101003055490000_CIT0009","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jpeds.2010.08.019","article-title":"Incidence and risk factors influencing the development of vancomycin nephrotoxicity in children","volume":"158","author":"McKamy","year":"2011","journal-title":"J Pediatr"},{"key":"2019101003055490000_CIT0010","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1007\/s004670050386","article-title":"Nephrotoxicity of beta-lactam antibiotics: mechanisms and strategies for prevention","volume":"11","author":"Tune","year":"1997","journal-title":"Pediatr Nephrol"},{"key":"2019101003055490000_CIT0011","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/phar.1428","article-title":"Comparison of acute kidney injury during treatment with vancomycin in combination with piperacillin\u2013tazobactam or cefepime","volume":"34","author":"Gomes","year":"2014","journal-title":"Pharmacotherapy"},{"key":"2019101003055490000_CIT0012","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/phar.1442","article-title":"Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin\u2013tazobactam","volume":"34","author":"Burgess","year":"2014","journal-title":"Pharmacotherapy"},{"key":"2019101003055490000_CIT0013","first-page":"332","article-title":"Does combination therapy with vancomycin and piperacillin\u2013tazobactam increase the risk of nephrotoxicity versus vancomycin alone in pediatric patients","volume":"21","author":"McQueen","year":"2016","journal-title":"J Pediatr Pharmacol Ther"},{"key":"2019101003055490000_CIT0014","article-title":"Assocation of acute kidney injury with concomitant vancomycin and piperacillin\/tazobactam treatment among hospitalized children. JAMA Pediatr 2017; 171: e173219 Available at:","author":"Downes"},{"key":"2019101003055490000_CIT0015","first-page":"179","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120.4","author":"Khwaja","year":"2013","journal-title":"Nephron Clin Pract"},{"key":"2019101003055490000_CIT0016","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1097\/PCC.0b013e3182745675","article-title":"Pediatric risk, injury, failure, loss, end-stage renal disease score identifies acute kidney injury and predicts mortality in critically ill children: a prospective study","volume":"14","author":"Soler","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"2019101003055490000_CIT0017","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/pbc.24720","article-title":"Suspected piperacillin\u2013tazobactam induced nephrotoxicity in the pediatric oncology population","volume":"61","author":"Pratt","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"2019101003055490000_CIT0018","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"2019101003055490000_CIT0019","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/pr.2017.116","article-title":"Electronic health record-based predictive models for acute kidney injury screening in pediatric inpatients","volume":"82","author":"Wang","year":"2017","journal-title":"Pediatr Res"},{"key":"2019101003055490000_CIT0020","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1053\/j.ajkd.2015.07.019","article-title":"Acute kidney injury incidence in noncritically ill hospitalized children, adolescents, and young adults: a retrospective observational study","volume":"67","author":"McGregor","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"2019101003055490000_CIT0021","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/ppul.23718","article-title":"Piperacillin\u2013tazobactam versus cefepime incidence of acute kidney injury in combination with vancomycin and tobramycin in pediatric cystic fibrosis patients","volume":"52","author":"LeCleir","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"2019101003055490000_CIT0022","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/cid\/cix379","article-title":"The effect of a piperacillin\/tazobactam shortage on antimicrobial prescribing and Clostridium difficile risk in 88 US medical centers","volume":"65","author":"Gross","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2019101003055490000_CIT0023","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/cpt.726","article-title":"The nephrotoxicity of vancomycin","volume":"102","author":"Filippone","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"2019101003055490000_CIT0024","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1128\/AAC.03011-15","article-title":"Epidemiology of acute kidney injury among patients receiving concomitant vancomycin and piperacillin\u2013tazobactam: opportunities for antimicrobial stewardship","volume":"60","author":"Karino","year":"2016","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jpids\/article-pdf\/8\/3\/221\/30125163\/piy030.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jpids\/article-pdf\/8\/3\/221\/30125163\/piy030.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T03:15:13Z","timestamp":1570677313000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article\/8\/3\/221\/4953693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,26]]},"references-count":24,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,26]]},"published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/piy030","relation":{},"ISSN":["2048-7207"],"issn-type":[{"value":"2048-7207","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7]]},"published":{"date-parts":[[2018,3,26]]}}}